Laboratory Procurement 7 min readPublished

PeptideX Closed: What Happened, the TGA Peptide Crackdown and What Former Customers Can Do

What is known about the PeptideX Research closure, why Australian peptide suppliers are under pressure in 2026, and practical steps for refunds, scams and choosing a supplier.

PeptideX Closed: What Happened, the TGA Peptide Crackdown and What Former Customers Can Do

Key answer

PeptideX Research has stopped taking orders and has not published a reason we could verify. The closure follows the TGA's June 2026 decision to make unapproved peptide products a compliance priority, and other Australian storefronts have also paused. If you have an unfulfilled order, contact your bank or payment provider promptly and treat any request to pay again with suspicion.

If you have been searching “PeptideX closed”, “what happened to PeptideX” or “PeptideX alternative Australia”, this article sets out what can be verified, what cannot, and what former customers can practically do next.

A disclosure first. AUS Peptide Supply is a commercial supplier and was a competitor of PeptideX. We have kept to facts we can source, and we do not speculate about another business’s affairs. The supplier checks we suggest below apply to us too.

What happened to PeptideX?

PeptideX Research traded online at peptidexresearch.com. When we reviewed its public catalogue for our Australian price comparison on 22 October 2026, it listed 42 active product sizes. It also advertised 30% off for payment in cryptocurrency. As of early November 2026, it is no longer taking orders.

PeptideX has not published a reason for closing that we have been able to verify. We have found no public TGA notice naming the business, and we are not suggesting it was the subject of regulatory action. Several pressures are closing or pausing Australian peptide storefronts this year, and any one of them could be the cause.

Several businesses use similar names. This article concerns PeptideX Research. Check the website address on your order confirmation or bank statement to confirm which business you dealt with.

Why are Australian peptide suppliers closing in 2026?

The TGA made unapproved peptides a compliance priority

On 10 June 2026 the Therapeutic Goods Administration expanded its compliance priority focus areas to include unapproved peptide products. newsGP reported that the TGA described this as a scaling up of regulatory attention. It cited increased importation, expanded online advertising and supply, and emerging safety concerns.

The TGA’s stated regulatory responses include infringement notices, product seizures, import interventions and, where appropriate, civil or criminal penalties. The same report described an eight-month joint operation by the TGA, Australian Border Force and Victoria Police. It led to the seizure of $2 million worth of peptide products, performance and image enhancing drugs and illicit steroids.

Nine days later, the TGA and the Chief Medical Officer issued a joint statement on unapproved peptides. It names BPC-157, TB-500, CJC-1295 and retatrutide among peptide products that are not included in the Australian Register of Therapeutic Goods (ARTG). Products outside the ARTG have not been evaluated by the TGA for safety, quality or effectiveness. The statement also describes serious adverse effects reported in people using this category of product.

How the TGA looks at these products

Australian regulation turns on a few defined terms. These are the ones that come up most often in TGA guidance on peptides.

Regulatory terms used in TGA peptide guidance
TermWhat it means in practice
Therapeutic goodUnder the Therapeutic Goods Act 1989, a product represented in any way to be, or likely to be taken to be, for therapeutic use. How a product is presented and promoted matters, not just what its label says.
ARTGThe Australian Register of Therapeutic Goods. A therapeutic good generally must be included in the ARTG before it can be lawfully supplied in Australia.
Unapproved productA product not included in the ARTG. The TGA has not assessed its safety, quality or effectiveness.
Schedule 4The Prescription Only Medicine category of the Poisons Standard. Sport Integrity Australia lists BPC-157 under Schedule 4 and Appendix D, which adds possession and supply controls.
AdvertisingPromotion of therapeutic goods to the public, including on websites and social media. The TGA has named online advertising of peptides as part of its compliance focus.

A “research use only” or “not for human consumption” label is not evidence of TGA approval. The TGA’s guidance for importers and suppliers sets out its view of their responsibilities, and anyone importing or supplying peptides should read it directly. Approval, importation, advertising and supply are separate legal questions. This article is general information, not legal advice.

Payment and advertising platforms are also pulling back

Regulation is not the only pressure. Card processors, payment platforms and banks can close merchant accounts in categories they regard as high risk. Major advertising platforms restrict promotion of unapproved pharmaceuticals and supplements. A store that loses its payment processing or its main source of traffic can become unviable quickly, without any regulator involved.

PeptideX is not the only closure

Our 22 October 2026 review covered 17 Australian supplier websites. Three had ordering unavailable at the time of review, and one stated that it had paused all new orders. Closed and paused storefronts stay visible in the comparison tool for reference but are excluded from current totals.

I have an unfulfilled PeptideX order. What can I do?

Start by gathering your records: the order confirmation, the payment receipt or bank statement entry, and any emails or messages with the business. Then contact whoever processed your payment. Act quickly, because most dispute processes have time limits.

First steps by payment method
How you paidFirst stepWhat to expect
Credit or debit cardAsk your card issuer about a chargeback for goods not received.Card schemes set deadlines, so contact your issuer as soon as possible.
PayPalOpen a dispute in PayPal’s Resolution Centre.Eligibility depends on PayPal’s current buyer protection terms.
Bank transfer or PayIDCall your bank and ask it to attempt a recall of the payment.A recall depends on the receiving bank and whether funds remain. It is not guaranteed.
CryptocurrencyKeep the transaction ID and wallet addresses.Crypto payments generally cannot be reversed. Be wary of anyone offering to recover them for a fee.

If you believe you have been deliberately defrauded, you can report it to Scamwatch. Your state or territory consumer protection agency may also be able to help with a business that has stopped responding.

Watch for scams after a supplier closes

A store closure is a common hook for scams. Customers are anxious, the original business has stopped responding, and lists of former customers can circulate. Treat these with suspicion:

  • “We’ve moved” messages that ask you to pay into a new bank account or wallet, or to pay again to release an order.
  • Lookalike websites using a similar name or domain that claim to be the same business relaunched.
  • Social media accounts offering to fulfil outstanding PeptideX orders for a fee. No other supplier can fulfil another business’s orders.
  • Unsolicited recovery services promising to get your money back, especially for crypto payments, in exchange for an upfront fee.

Verify any claim through a channel you already trusted, not through the message itself. When paying by PayID, your banking app shows the registered account name before you confirm. Check that it matches the business you think you are paying.

What should I do with PeptideX products I still have?

The TGA’s warnings are clear that, for unapproved peptide products, the label cannot tell you exactly what is in the vial, where it was made or whether it is sterile. Products from a supplier that has since closed also come with no ongoing support, recall process or way to check a batch.

For any question about your own health, speak to a GP or pharmacist. If you have experienced a side effect after using a peptide product, seek medical advice. You can also report suspected side effects to the TGA. Many community pharmacies accept unwanted medicines for disposal through the Return Unwanted Medicines (RUM) Project, so ask your local pharmacy whether it can take the item.

How to choose a supplier for laboratory research after PeptideX

If you need research material for laboratory work, a supplier closure is a good moment to tighten how you evaluate suppliers. These checks work for any supplier, including us.

  1. Confirm who the business is. Look for a registered entity name and an ABN you can check on the public ABN Lookup register, plus contact details that actually get a reply.
  2. Read the analytical reports, not just the purity figure. A useful certificate of analysis names the testing laboratory, carries a report ID you can verify, and matches the batch you will receive. Identity testing by mass spectrometry and purity by HPLC answer different questions. Our HPLC explainer covers the difference.
  3. Know who you are paying and what recourse you have. A large discount for paying in cryptocurrency is common in this market. It also removes most of your options if an order never arrives.
  4. Look at how the products are presented. A supplier that publishes human dosing protocols, before-and-after results or treatment claims is presenting its products for therapeutic use. That is the conduct the TGA’s compliance priority targets, and it puts the supplier’s continuity at risk as well as you.
  5. Compare the delivered cost. Compare the same compound and vial size, then add shipping and any conditions attached to discounts. The price comparison tool does this across a sample of Australian suppliers, and the supplier worksheet gives you a template to record the answers.

If you are evaluating AUS Peptide Supply, our business details and ABN are on the about page, batch reports are in the certificate of analysis index, and delivery options are on the shipping page. We supply research materials for laboratory use only. They are not for human or veterinary use, and we cannot advise on personal use.

PeptideX closure: frequently asked questions

Is PeptideX coming back?

We do not know, and PeptideX has not said. If you see a relaunch announced, verify it through the original domain or a contact you already had. Be especially careful with any request to make a payment to new account details.

Was PeptideX shut down by the TGA?

We have found no public TGA notice naming PeptideX. The TGA publishes many of its enforcement outcomes, such as infringement notices and court results, on its website. Check there rather than relying on forum or social media rumours.

It depends on the product and the activity. Some peptide medicines are included in the ARTG and supplied on prescription. Many peptides sold online are not, and the TGA has made the unlawful importation, advertising, manufacture and supply of unapproved peptide products a compliance priority. Some, such as BPC-157, are also listed in Schedule 4 of the Poisons Standard. For a specific situation, check current TGA information or get legal advice.

Can another supplier fulfil my PeptideX order?

No. Orders, payments and customer records belong to the business you bought from. Anyone offering to honour a PeptideX order or transfer your credit is a red flag.

Is there a PeptideX alternative in Australia?

Several Australian suppliers are still trading, but they differ in documentation, pricing and how they present their products. Use the checks above and compare like for like before switching. The comparison tool shows prices for the same vial sizes across a sample of Australian suppliers.

Sources and further reading

  1. TGA strengthens compliance focus on unapproved peptide products as part of evolving risk responseTherapeutic Goods Administration — media release, June 2026
  2. TGA targets illegal peptides in new compliance crackdownnewsGP, Royal Australian College of General Practitioners — 10 June 2026
  3. TGA and Chief Medical Officer statement on unapproved peptidesTherapeutic Goods Administration — 19 June 2026
  4. Understanding your responsibilities when importing, compounding and supplying unapproved peptide productsTherapeutic Goods Administration — safety alert, 2026
  5. BPC-157 substance profileSport Integrity Australia
  6. Report a scamScamwatch — Australian Competition and Consumer Commission

Continue your research